Federal agencies have updated their guidance for handling Category A solid waste, including waste that may be contaminated with monkeypox virus.
News
Latest
AHA released the first report in a three-part series that will offer immediate and longer term strategies to help hospital and health system leaders navigate workforce challenges and opportunities.
The AHA’s American Society for Health Care Risk Management is celebrating Health Care Risk Management Week.
Organizations can apply through July 29 for a portion of $10 million in funding to expand access to medication-assisted treatment for opioid use disorder in rural communities, the HRSA announced.
CMS issued its calendar year 2023 proposed rule for the home health prospective payment system, which would reduce net HH payments by $810 million in calendar year 2023 relative to CY 2022.
Dispensing rates of prescriptions for COVID-19 antiviral pills were lowest in the most socially and economically disadvantaged communities, according to a study released by the CDC.
The CDC's Advisory Committee on Immunization Practices on Saturday recommended the Moderna vaccine and the Pfizervaccine for children of certain ages.
Commenting today on the proposed rule for the inpatient prospective payment system for fiscal year 2023, AHA today urged the Centers for Medicare & Medicaid Services to adjust the market basket update to account for the unprecedented inflationary environment hospitals and health systems are experiencing, and eliminate the productivity cut.
Leon Caldwell, AHA senior director of health equity strategies and innovation, talks with James Min, M.D., CEO and co-founder of Cleerly, and Richard Chazal, M.D., senior cardiologist and medical director at Lee Health System’s Heart & Vascular Institute, about their transformative approach to heart care and its impact on health equity.
The Department of Health and Human Services yesterday launched “I am a Work of ART,” a national campaign to encourage people with HIV to seek or continue care and antiretroviral therapy, part of the national strategy to end the HIV epidemic by 2030.
The Food and Drug Administration today authorized Moderna’s COVID-19 vaccine for children aged 6 months through 17 years old and Pfizer’s COVID-19 vaccine for children aged 6 months through 4 years old, as recommended this week by its vaccine advisory committee.
Two studies released last week during Community Health Improvement Week highlight the tremendous value hospitals provide to benefit their communities.
A new special issue of Health Services Research focuses on how health care organizations can use implementation science and community-engaged research methods to improve population health and reduce care disparities.
“Understanding potential costs is an important part of the patient experience when planning for care, and hospitals and health systems are committed to helping patients navigate that process,” writes Ari Levin, AHA’s director of coverage policy.
The Centers for Medicare & Medicaid Services today approved state plan amendments allowing Maine, Minnesota, New Mexico and Washington, D.C., to extend postpartum coverage from 60 days to 12 months after pregnancy for Medicaid and Children’s Health Insurance Program enrollees under the American Rescue Plan Act
COVID-19 hospitalization rates are about 50% higher for adults eligible for Medicare because of a disability than for other adults enrolled in Medicare.
President Biden yesterday directed the Health and Human Services Secretary to develop and release sample policies for states “to safeguard and expand access to health care for LGBTQI+ individuals and their families, including mental health services.”
A Food and Drug Administration advisory committee today recommended the agency authorize Moderna’s COVID-19 two-dose vaccine for children aged 6 months through 5 years old and Pfizer’s three-dose COVID-19 vaccine for children aged 6 months through 4 years old
The National Center for Healthcare Leadership is accepting nominations through July 8 for the 2022 Gail L. Warden Leadership Excellence Award.
The Food and Drug Administration Friday authorized the first COVID-19 test to identify and differentiate certain SARS-CoV-2 lineages in respiratory samples that test positive for the virus.